Evidence map›Paper›PMID 28955453›Full record

ArticleFungal biology and biotechnology2015

K Stefan Svahn, Erja Chryssanthou, Björn Olsen, Lars Bohlin, Ulf Göransson

Open access · goldAbstract read
In one paragraph

Article in Fungal biology and biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Viridicatin from the Antarctic FungusAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Mycology · 2025
    Article
  3. Review
  4. Article
  5. Ecological Characteristics of Antarctic Fungi.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2023
    Review
  6. Review
  7. Article
  8. Enzymatic and Antimicrobial Activities in Polar Strains of Microscopic Soil Fungi.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2022
    Article
  9. Liposomes: Biomedical Applications.Chonnam medical journal · 2021
    Review
  10. Extracellular Enzymes and Bioactive Compounds from Antarctic Terrestrial Fungi for Bioprospecting.International journal of environmental research and public health · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Biopharmaceuticals from microorganisms: from production to purification.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2016
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

K Stefan SvahnDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Erja ChryssanthouDepartment of Clinical Microbiology, Karolinska University Hospital & Karolinska Institute, Stockholm, Sweden.
Björn OlsenDepartment of Medical Sciences and Zoonosis Science Centre IMBIM, Uppsala University, Uppsala, Sweden.
Lars BohlinDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Ulf GöranssonDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Uppsala University · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe need for new antibiotic drugs increases as pathogenic microorganisms continue to develop resistance against current antibiotics. We obtained samples from Antarctica as part of a search for new antimicrobial metabolites derived from filamentous fungi. This terrestrial environment near the South Pole is hostile and extreme due to a sparsely populated food web, low temperatures, and insufficient liquid water availability. We hypothesize that this environment could cause the development of fungal defense or survival mechanisms not found elsewhere.

resultsWe isolated a strain of

conclusionsThese results encourage further investigation of the many unexplored sampling sites characterized by extreme conditions, and confirm filamentous fungi as potential sources of metabolites with antimicrobial activity.

Indexed as

Amphotericin BAntarcticaPenicillium nalgiovense Laxa

Identifiers

PMID28955453
PMCPMC5611601
OpenAlexW2103190438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.